Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P0
Near historical low
vs 2Y Ago
-170.4x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-287.13%
202480.21%
20231.69%
2022-38.87%
2021-13.19%
2020-22.15%
2019-75.01%
2018-45.69%
20170.00%